ILCA GUIDANCE FOR MANAGEMENT OF HCC DURING COVID-19 PANDEMIC

ILCA developed a guidance document on recommendations for the management of patients with liver cancer in the COVID19 pandemic. This guidance document has been put together with the help and knowledge of ILCA Education Committee and Executive Committee. Download the Management of HCC during COVID-19: ILCA Guidance8th April 2020